Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
about
Phosphate binders in chronic kidney disease: a systematic review of recent data.Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis.Contemporary management of phosphorus retention in chronic kidney disease: a review.Factors associated with corneal epithelial defects after pars plana vitrectomy.Estimates of health utility scores in chronic kidney disease.Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional studyA Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on D
P2860
Q31039292-D995C75E-C482-4649-8A90-95C6A67C3E56Q35988756-C5070D62-B2DA-4471-90B6-E9CE0A4B4220Q37204047-E6AF97EA-7E02-4104-B189-03601A2E6317Q38374335-61145F29-8D5D-42F9-8A9F-CE7E2AE8F0AFQ38511621-CBBC10CE-D6A2-4B7A-8E05-58C159F5A69AQ39041725-B816A812-AEF4-47C5-9C9D-68F1D7313E48Q40112709-80886608-AF59-4DC2-834B-CC5E38F84340Q51743408-A447641B-8B77-4BB7-A048-F2B9234C1760Q53775627-F8ABE502-0041-4297-AD1E-EA4E4D0ED09EQ55383536-270D9AE6-8963-4030-B1F7-EAB1495E3F54Q58866156-5508A3A2-F314-4F2A-BBEA-11CC94283F76Q59109974-36449965-8F7A-4B31-A030-16BEE3C17A69
P2860
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hyperphosphatemia in patients ...... comes with treatment adherence
@ast
Hyperphosphatemia in patients ...... comes with treatment adherence
@en
Hyperphosphatemia in patients ...... comes with treatment adherence
@nl
type
label
Hyperphosphatemia in patients ...... comes with treatment adherence
@ast
Hyperphosphatemia in patients ...... comes with treatment adherence
@en
Hyperphosphatemia in patients ...... comes with treatment adherence
@nl
prefLabel
Hyperphosphatemia in patients ...... comes with treatment adherence
@ast
Hyperphosphatemia in patients ...... comes with treatment adherence
@en
Hyperphosphatemia in patients ...... comes with treatment adherence
@nl
P2860
P356
P1433
P1476
Hyperphosphatemia in patients ...... comes with treatment adherence
@en
P2093
Anjay Rastogi
P2860
P2888
P356
10.1186/1471-2369-14-153
P407
P50
P5008
P577
2013-07-18T00:00:00Z
P5875
P6179
1033886653